Relay’s “State of Cybersecurity” Panel LIVE Tuesday
TORONTO, June 18, 2021 - Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) - will be hosting the inaugural Cybersecurity panel discussion Tuesday, June 22, 2021 at 1pm EDT.
The “State of Cybersecurity” event features cybersecurity expert panelists Chris Blask and Chuck Brooks, and Cybeats co-founder and CTO Dmitry Raidman. The live event is moderated by Evgeniy Kharam and a recording of the webcast will be made available for viewing on the Cybeats YouTube channel following the broadcast.
Key topics of discussion are to include the recent Executive Order issued by the US President, and other newsworthy developments related to the global cybersecurity, and Internet of Things (IoT) sectors.
To attend Tuesday's complementary live event, or to submit questions to the panel, you can register here: https://stateofcybersecurityindustry.splashthat.com/
About Cybeats
Cybeats’ SBOM Studio product allows for the monitoring and analysis of cybersecurity on all components during the design and manufacturing stage ensuring connected devices have been developed with secure software components.
Cybeats’ IoT security platform’s capabilities span across detecting and mitigating attacks on devices while they are operational, to enabling device makers to identify and fix security flaws during the product’s design phase and empowering end users with fleet management tools such as secure firmware updates.
Media Inquiries contact: Destine Lee [email protected] | 647-872-9982
SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news
About Relay Medical Corp.
Relay Medical is an innovation Company headquartered in Toronto, Canada focused on the cultivation of novel solutions in the diagnostics and AI data science and IoT security sectors.
Website: www.relaymedical.com
Contact:
W. Clark Kent
President
Relay Medical Corp.
Office. 647-872-9982 ext. 2
TF. 1-844-247-6633 ext. 2
Bernhard Langer
EU Investor Relations
Office. +49 (0) 177 774 2314
Email: [email protected]
Contact:
Office: 647-872-9982
Toll-free/Fax: 1-844-247-6633
Email: [email protected]
65 International Blvd. Suite 202
Etobicoke, Ontario M9W 6L9
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com
